Literature DB >> 12829617

Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes.

Mohit Jain1, Daniel A Brenner, Lei Cui, Chee Chew Lim, Bo Wang, David R Pimentel, Stanley Koh, Douglas B Sawyer, Jane A Leopold, Diane E Handy, Joseph Loscalzo, Carl S Apstein, Ronglih Liao.   

Abstract

Reactive oxygen species (ROS)-mediated cell injury contributes to the pathophysiology of cardiovascular disease and myocardial dysfunction. Protection against ROS requires maintenance of endogenous thiol pools, most importantly, reduced glutathione (GSH), by NADPH. In cardiomyocytes, GSH resides in two separate cellular compartments: the mitochondria and cytosol. Although mitochondrial GSH is maintained largely by transhydrogenase and isocitrate dehydrogenase, the mechanisms responsible for sustaining cytosolic GSH remain unclear. Glucose-6-phosphate dehydrogenase (G6PD) functions as the first and rate-limiting enzyme in the pentose phosphate pathway, responsible for the generation of NADPH in a reaction coupled to the de novo production of cellular ribose. We hypothesized that G6PD is required to maintain cytosolic GSH levels and protect against ROS injury in cardiomyocytes. We found that in adult cardiomyocytes, G6PD activity is rapidly increased in response to cellular oxidative stress, with translocation of G6PD to the cell membrane. Furthermore, inhibition of G6PD depletes cytosolic GSH levels and subsequently results in cardiomyocyte contractile dysfunction through dysregulation of calcium homeostasis. Cardiomyocyte dysfunction was reversed through treatment with either a thiol-repleting agent (L-2-oxothiazolidine-4-carboxylic acid) or antioxidant treatment (Eukarion-134), but not with exogenous ribose. Finally, in a murine model of G6PD deficiency, we demonstrate the development of in vivo adverse structural remodeling and impaired contractile function over time. We, therefore, conclude that G6PD is a critical cytosolic antioxidant enzyme, essential for maintenance of cytosolic redox status in adult cardiomyocytes. Deficiency of G6PD may contribute to cardiac dysfunction through increased susceptibility to free radical injury and impairment of intracellular calcium transport. The full text of this article is available online at http://www.circresaha.org.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829617     DOI: 10.1161/01.RES.0000083489.83704.76

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  55 in total

1.  Oxidoreductase regulation of Kv currents in rat ventricle.

Authors:  Huixu Liang; Xun Li; Shumin Li; Ming-Qi Zheng; George J Rozanski
Journal:  J Mol Cell Cardiol       Date:  2008-03-28       Impact factor: 5.000

2.  Comparative Gene Expression Analyses Reveal Distinct Molecular Signatures between Differentially Reprogrammed Cardiomyocytes.

Authors:  Yang Zhou; Li Wang; Ziqing Liu; Sahar Alimohamadi; Chaoying Yin; Jiandong Liu; Li Qian
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

Review 3.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

4.  Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart.

Authors:  Claudio Vimercati; Khaled Qanud; Gianfranco Mitacchione; Danuta Sosnowska; Zoltan Ungvari; Roberto Sarnari; Daniella Mania; Neel Patel; Thomas H Hintze; Sachin A Gupte; William C Stanley; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

5.  Metabolomics reveals critical adrenergic regulatory checkpoints in glycolysis and pentose-phosphate pathways in embryonic heart.

Authors:  Jessica N R Peoples; Timmi Maxmillian; Quynh Le; Sergiy M Nadtochiy; Paul S Brookes; George A Porter; Victor L Davidson; Steven N Ebert
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

6.  Modulation of glucose-related metabolic pathways controls glucose level in airway surface liquid and fight oxidative stress in cystic fibrosis cells.

Authors:  M Favia; L de Bari; R Lassandro; Anna Atlante
Journal:  J Bioenerg Biomembr       Date:  2019-04-27       Impact factor: 2.945

7.  Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.

Authors:  Cameron Donaldson; Sarah Eder; Corey Baker; Mark J Aronovitz; Alexandra Dabreo Weiss; Monica Hall-Porter; Feng Wang; Adam Ackerman; Richard H Karas; Jeffery D Molkentin; Richard D Patten
Journal:  Circ Res       Date:  2008-12-12       Impact factor: 17.367

Review 8.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

9.  Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.

Authors:  Kayla M Pound; Natalia Sorokina; Kalpana Ballal; Deborah A Berkich; Mathew Fasano; Kathryn F Lanoue; Heinrich Taegtmeyer; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

Review 10.  Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium.

Authors:  Deborah A Siwik; Wilson S Colucci
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.